A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene

被引:15
|
作者
Gong, Hui [1 ]
Tang, Zhengyi [1 ]
Yang, Yang [1 ]
Sun, Lihao [1 ]
Zhang, Wei [1 ]
Wang, Weiqing [1 ]
Cui, Bin [1 ,2 ,3 ]
Ning, Guang [1 ,2 ,3 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Endocrinol & Metab,Shanghai Clin Ct, Shanghai 200025, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Lab Endocrine & Metab Dis, Shanghai 200025, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Univ, Div Endocrine & Metab Dis, Shanghai 200025, Peoples R China
关键词
Pseudohypoaldosteronism type II; WNK4; gene; Mutation;
D O I
10.1007/s12020-008-9084-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pseudohypoaldosteronism Type H (PHAII) is a very rare disorder characterized by hyperkalemia, hypertension, and slight hyper-chloremic metabolic acidosis. The index patient showed typical features of PHAII, including elevated blood pressure (140-150/90-100 mmHg), hyperkalemia in the range of 5.30-5.60 mmol/l (normal range is 3.50-5.10 mmol/l), accompanied by hyperchloremia of 109.5-112.0 mmol/l (normal 95.0-108.0 mmol/l) and acidosis with bicarbonate levels of 19.5-20.1 mmol/l (normal 22.0-27.0), GFR was 98.95 ml/min (normal > 90). However, these features were absent in his parents. Sequencing analysis found the patient with a WNK4 gene mutation, 1682 C > T in Exon 7, which resulted a missense mutation at codon 561 (P561L). The variation in codon 561 was not found in his parents and 100 unrelated control subjects. The identified WNK4 mutation which has not been described previously is the probable cause of PHAII.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 50 条
  • [1] A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene
    Hui Gong
    Zhengyi Tang
    Yang Yang
    Lihao Sun
    Wei Zhang
    Weiqing Wang
    Bin Cui
    Guang Ning
    Endocrine, 2008, 33 : 230 - 234
  • [2] Identification of a Novel WNK4 Mutation in Chinese Patients with Pseudohypoaldosteronism Type II
    Zhang, Chong
    Wang, Zhaohui
    Xie, Jingyuan
    Yan, Fuhong
    Wang, Weiming
    Feng, Xiaobei
    Zhang, Wen
    Chen, Nan
    NEPHRON PHYSIOLOGY, 2011, 118 (03): : P53 - P61
  • [3] SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation
    Chu, Pei-Yi
    Cheng, Chih-Jen
    Wu, Yi-Chang
    Fang, Yu-Wei
    Chau, Tom
    Uchida, Shinichi
    Sasaki, Sei
    Yang, Sung-Sen
    Lin, Shih-Hua
    PLOS ONE, 2013, 8 (09):
  • [4] Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene
    Brooks, A. M.
    Owens, M.
    Sayer, J. A.
    Salzmann, M.
    Ellard, S.
    Vaidya, B.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (08) : 791 - 794
  • [5] A new kindred with Pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene
    Golbang, AP
    Murthy, M
    Hamad, A
    Liu, CH
    Cope, G
    Van't Hoff, W
    Cuthbert, A
    O'Shaughnessy, KM
    HYPERTENSION, 2005, 46 (02) : 295 - 300
  • [6] WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3
    Susa, Koichiro
    Sohara, Eisei
    Takahashi, Daiei
    Okado, Tomokazu
    Rai, Tatemitsu
    Uchida, Shinichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 491 (03) : 727 - 732
  • [7] Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade
    Chiga, Motoko
    Rafiqi, Fatema H.
    Alessi, Dario R.
    Sohara, Eisei
    Ohta, Akihito
    Rai, Tatemitsu
    Sasaki, Sei
    Uchida, Shinichi
    JOURNAL OF CELL SCIENCE, 2011, 124 (09) : 1391 - 1395
  • [8] A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4
    Sakoh, Takashi
    Sekine, Akinari
    Mori, Takayasu
    Mizuno, Hiroki
    Kawada, Masahiro
    Hiramatsu, Rikako
    Hasegawa, Eiko
    Hayami, Noriko
    Yamanouchi, Masayuki
    Suwabe, Tatsuya
    Sawa, Naoki
    Ubara, Yoshifumi
    Fujimaru, Takuya
    Sohara, Eisei
    Shinichi, Uchida
    Hoshino, Junichi
    Takaichi, Kenmei
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (06):
  • [9] Mechanisms for Hypercalciuria in Pseudohypoaldosteronism Type II-Causing WNK4 Knock-In Mice
    Yang, Sung-Sen
    Hsu, Yu-Juei
    Chiga, Motoko
    Rai, Tatemitsu
    Sasaki, Sei
    Uchida, Shinichi
    Lin, Shih-Hua
    ENDOCRINOLOGY, 2010, 151 (04) : 1829 - 1836
  • [10] Hyperkalemia in pseudohypoaldosteronism type 2 can be from mutated WNK4, but more often from impaired ubiquitination of normal WNK4
    Healy, John K.
    KIDNEY INTERNATIONAL, 2020, 98 (03) : 784 - 785